Insulin aspart, recombinant Subcutaneous and Vepesid Oral
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Vepesid Oral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: etoposide
Brand name: VePesid, Etopophos, Toposar
Synonyms: VePesid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Veramyst
- Insulin aspart, recombinant Subcutaneous-Veramyst Nasal
- Insulin aspart, recombinant Subcutaneous-Verapamil
- Insulin aspart, recombinant Subcutaneous-Verapamil Extended Release Capsules
- Insulin aspart, recombinant Subcutaneous-Verapamil Extended Release Tablets
- Insulin aspart, recombinant Subcutaneous-Verapamil Hydrochloride
- Vepesid Oral-Insulin degludec
- Vepesid Oral-Insulin Degludec (U-100) Prefilled Pens
- Vepesid Oral-Insulin Degludec (U-100) Vials
- Vepesid Oral-Insulin Degludec (U-200) Prefilled Pens
- Vepesid Oral-Insulin degludec and liraglutide
- Vepesid Oral-Insulin degludec and liraglutide Subcutaneous